AACR Cancer Progress Report 2022 shows continued decline in cancer death rates, and genetic tests create opportunities but also confusion for breast cancer patients.

by Eric Fitzsimmons

Air pollution research provides clues to how cancer starts, and KRAS-targeting drug appears to keep cancer at bay longer than standard of care, but questions remain

by Marci A. Landsmann

Early-onset cancer is increasing globally, and testing population-wide preventive DNA testing.

by Kevin McLaughlin

Fertility preservation does not impact outcomes for breast cancer patients, and ultraprocessed foods linked to increased risk of colorectal cancer in men.

by Thomas Celona

Advanced cervical cancer rates are rising despite prevention and screening tools, and CAR T-cell therapy inaccessible to many across the country.

by Eric Fitzsimmons

Link found between fracking wells and leukemia in children, and accurate reporting of cancer outcomes urged for Native Hawaiians and Pacific Islanders.

by Kevin McLaughlin

Drug for HER2-positive cancer receives further approvals, and researchers study the risk of lung cancer from wildfires.

by Marci A. Landsmann

Study finds majority of patients treated with chemotherapy experience hearing loss, and ‘rogue’ online pharmacies found to be dispensing oncology drugs.

by Thomas Celona

Cancer patients and doctors concerned about how abortion bans will affect treatment, and resistant starch supplements lower risk of many cancers in people with Lynch syndrome.

by Eric Fitzsimmons

Drug shortages in hematology oncology, and cancer centers don’t accept Medicaid.

by Marci A. Landsmann